HIV-positive patients who took statins were 46% less likely to develop cancer than those not on statin therapy, according to a study presented at the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. "We looked at more than 10 years of treatment records and we found that the protection of statins was even greater when we considered cancers that are considered AIDS-defining illnesses -- non-Hodgkin lymphoma, Kaposi's sarcoma and uterine cervical cancer," the lead author said.

Related Summaries